EstechPharma Co. Ltd Total Liabilities
EstechPharma Co. Ltd total liabilities. Based on the latest financial reports, EstechPharma Co. Ltd (041910) has total liabilities worth ₩60.00 Billion KRW (≈ $40.66 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of EstechPharma Co. Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of EstechPharma Co. Ltd (2013–2025)
Total liabilities of EstechPharma Co. Ltd from 2013 to 2025. This chart illustrates how EstechPharma Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore EstechPharma Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
EstechPharma Co. Ltd Competitors by Total Liabilities
The table below lists competitors of EstechPharma Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OS Therapies Incorporated
NYSE MKT:OSTX
|
USA | $4.25 Million |
|
Oceanpal Inc
NASDAQ:OP
|
USA | $4.10 Million |
|
Adaptimmune Therapeutics plc
F:473A
|
Germany | €201.59 Million |
|
Elron Electronic Industries Ltd
TA:ELRN
|
Israel | ILA13.15 Million |
|
Rank Progress S.A.
WAR:RNK
|
Poland | zł354.38 Million |
|
Brunswick Exploration Inc
V:BRW
|
Canada | CA$965.97K |
|
Golden House
TA:GOHO
|
Israel | ILA141.57 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down EstechPharma Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 041910 total asset value.
Liquidity & Leverage Metrics
EstechPharma Co. Ltd Total Liabilities Ratios Explained
EstechPharma Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EstechPharma Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EstechPharma Co. Ltd (2013–2025)
The table below shows the annual total liabilities of EstechPharma Co. Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩60.00 Billion ≈ $40.66 Million |
+922.48% |
| 2024-12-31 | ₩5.87 Billion ≈ $3.98 Million |
-6.35% |
| 2023-12-31 | ₩6.27 Billion ≈ $4.25 Million |
-23.86% |
| 2022-12-31 | ₩8.23 Billion ≈ $5.58 Million |
-25.60% |
| 2021-12-31 | ₩11.06 Billion ≈ $7.50 Million |
-5.90% |
| 2020-12-31 | ₩11.76 Billion ≈ $7.97 Million |
-14.23% |
| 2019-12-31 | ₩13.71 Billion ≈ $9.29 Million |
+50.71% |
| 2018-12-31 | ₩9.09 Billion ≈ $6.16 Million |
-27.66% |
| 2017-12-31 | ₩12.57 Billion ≈ $8.52 Million |
-37.30% |
| 2016-12-31 | ₩20.05 Billion ≈ $13.59 Million |
+4.22% |
| 2015-12-31 | ₩19.24 Billion ≈ $13.04 Million |
-50.12% |
| 2014-12-31 | ₩38.57 Billion ≈ $26.14 Million |
+5.92% |
| 2013-12-31 | ₩36.41 Billion ≈ $24.68 Million |
-- |
About EstechPharma Co. Ltd
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.